Initial Prior Authorization Tacrolimus Ointment
Customize your policy alerts
Sign up for all cvs_caremark policy alerts
Know when cvs_caremark releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs initial and continuation prior authorization for tacrolimus ointment, including 0.03% and 0.1% strengths, for atopic dermatitis, psoriasis, and vitiligo. It applies to requests for both generic tacrolimus ointment and all dosage forms and strengths referenced by the document.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.